Use this URL to cite or link to this record in EThOS:
Title: Mucin expression in bladder cancer
Author: Yong, Sze Ming
ISNI:       0000 0001 3575 3887
Awarding Body: University of Aberdeen
Current Institution: University of Aberdeen
Date of Award: 2006
Availability of Full Text:
Access from EThOS:
Certain membrane bound mucins such as MUC1, MUC4, and MUC12 were expressed in normal bladder urothelium.  MUC1 expression was the highest in normal bladder urothelium and was present in almost all samples. In superficial bladder cancer, MUC1 demonstrated a pattern of expression that increased in proportion to the increase in tumour grade from Grade 1 to Grade 3 and carcinoma in situ.  Utilising TMAs, membrane-bound mucins such as MUC1, MUC3, MUC4, MUC12 and MUC 16 were shown to have increased incidence of expression with tumour stage progression  to muscle-invasive bladder cancer (stage T2 and above).  Secretory mucins showed a more varied pattern of expression.  MUC2 mRNA was up-regulated in progressive muscle-invasive bladder cancer.   MUC5AC and MUC5B displayed a low incidence of expression in superficial tumours and muscle invasive bladder cancer. MUC7 mRNA expression, however, was limited to only muscle-invasive disease similar to the membrane-bound mucins described above. In a small proportion of patients in the recurrent progressive TMA, expression of MUC4, MUC5AC and MUC5B in penultimate superficial tumours prior to tumour progression allowed prediction of impending disease progression to muscle invasive disease.  MUC5B, MUC12 and MUC13 were expressed at higher incidence in the single non-recurrent TMA, compared with the incidence of expression in the recurrent non-progressive TMA. The expression of these mucins in newly diagnosed superficial bladder tumours may thus favour better prognosis, with a subsequent reduced risk of tumour recurrence.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (M.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available